Obesity
Not recruitingOrlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity
Sweden- Participants:18–64 years · Healthy volunteers
- Substances:ACARBOSE
- Sponsor:Empros Pharma AB
Rare diseases
Investigational molecules
Locations

Nanna Svartz Vag 4, 171 65 Solna, Sweden
Empros Pharma AB focuses on clinical research in obesity, with interest in treatments that address body weight management and related metabolic care.
Its trial portfolio reflects a therapeutic emphasis on pharmacological interventions for obesity, including comparative evaluation of candidate agents and established reference treatments.
Empros Pharma AB runs clinical trials in conditions such as Obesity, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Sweden
SwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.